Pre-eclampsia: Abnormal Placentation, Endothelial Dysfunction, and Multisystem Disease
Pre-eclampsia is a pregnancy-specific disorder characterised by new-onset hypertension and systemic organ dysfunction after mid-pregnancy. It is not simply a blood pressure disorder, but a complex multisystem disease driven by placental pathology and widespread endothelial injury. Maternal symptoms can escalate rapidly, leading to multiple organ systems being affected. Delivery of the placenta is the only definitive cure.
What You Need to Know
Pre-eclampsia develops when normal placental implantation and vascular adaptation fail early in pregnancy. In a healthy pregnancy, uterine spiral arteries are remodelled into wide, low-resistance vessels capable of delivering a steady, high-volume blood supply to the placenta. In pre-eclampsia, this remodelling is incomplete, leaving the arteries narrow and responsive to vasomotor signals. Placental blood flow therefore becomes reduced and intermittent rather than continuous, exposing placental tissue to repeated episodes of relative hypoxia and reperfusion.
Placental stress triggers the release of bioactive factors into the maternal circulation. These factors disrupt normal endothelial function throughout the body, leading to vasoconstriction, increased vascular permeability, and activation of coagulation pathways. The maternal vascular system shifts toward a high-resistance, pro-inflammatory state, affecting multiple organs simultaneously rather than remaining confined to the uterus or placenta.
Several interconnected processes link abnormal placentation to the systemic features of disease:
Incomplete spiral artery remodelling produces reduced and fluctuating placental perfusion
Placental hypoxia stimulates release of anti-angiogenic and inflammatory mediators
Widespread endothelial dysfunction alters vascular tone, permeability, and organ perfusion
The clinical manifestations of pre-eclampsia therefore reflect a maternal response to placental failure rather than a primary maternal disorder. Hypertension arises from systemic vasoconstriction, proteinuria from glomerular endothelial injury, and oedema from increased capillary permeability. As endothelial dysfunction progresses, organs with high perfusion demands become particularly vulnerable, explaining the multisystem nature of the condition and its potential for rapid deterioration despite initially subtle symptoms.
Beyond the Basics
Abnormal placentation and reduced uteroplacental perfusion
In early pregnancy, trophoblastic cells normally invade deeply into maternal spiral arteries, replacing their muscular walls and transforming them into dilated, low-resistance vessels. This adaptation allows uteroplacental blood flow to increase progressively and remain stable as fetal metabolic demands rise. In pre-eclampsia, trophoblastic invasion is shallow and incomplete.
Spiral arteries retain their narrow calibre and responsiveness to vasomotor signals, so placental perfusion is reduced and intermittent rather than continuous. Repeated episodes of relative hypoxia place the placenta under sustained ischaemic stress, which becomes a central driver of downstream pathology.
Placental ischaemia and release of anti-angiogenic factors
Reduced and fluctuating placental blood flow triggers cellular stress responses within placental tissue. In response, the placenta releases anti-angiogenic and inflammatory mediators into the maternal circulation. These factors interfere with normal endothelial signalling, reduce nitric oxide availability, and disrupt vascular growth and repair mechanisms. Rather than remaining a local placental problem, these circulating mediators exert systemic effects, linking placental failure directly to widespread maternal vascular dysfunction.
Endothelial dysfunction and vasoconstriction
Healthy endothelium plays a key role in regulating vascular tone, permeability, and haemostatic balance. In pre-eclampsia, exposure to placental mediators damages endothelial cells and shifts vascular behaviour toward vasoconstriction, increased permeability, and pro-thrombotic activity. Generalised vasoconstriction raises systemic vascular resistance, producing hypertension. At the same time, increased capillary permeability allows fluid to move into the interstitial space, contributing to oedema and relative intravascular depletion despite overall fluid retention. These opposing fluid shifts reflect vascular dysfunction rather than simple volume overload.
Renal involvement and proteinuria
The kidneys are particularly vulnerable to endothelial injury because glomerular filtration depends on intact endothelial function. Damage to glomerular endothelium increases permeability, allowing plasma proteins to pass into the urine. Proteinuria therefore represents vascular injury at the level of the glomerulus rather than primary renal pathology. Reduced renal perfusion and altered filtration further promote sodium and water retention, amplifying hypertension and oedema. Renal findings are thus a manifestation of systemic endothelial disease rather than isolated kidney involvement.
Coagulation and microvascular injury
Endothelial activation in pre-eclampsia promotes platelet aggregation and microthrombus formation within small vessels. These changes impair microvascular perfusion and contribute to tissue hypoxia across multiple organs. In more severe disease, widespread platelet consumption and endothelial activation may progress toward consumptive coagulopathy. This state combines increased thrombotic risk with impaired clotting capacity, reflecting dysregulated haemostasis rather than simple bleeding or clotting disorders.
Multisystem organ dysfunction
Systemic endothelial dysfunction affects organs with high perfusion demands most prominently. Cerebral vasospasm and reduced autoregulation contribute to headaches, visual disturbance, and seizure risk. Hepatic involvement arises from microvascular injury and ischaemia within the liver, producing right upper quadrant pain and elevated liver enzymes. These features represent manifestations of diffuse vascular pathology rather than primary neurological or hepatic disease, explaining the breadth and unpredictability of clinical presentation.
Resolution with placental delivery
Delivery of the placenta removes the source of anti-angiogenic and inflammatory mediators driving maternal disease. Following placental removal, endothelial function gradually recovers, vascular tone normalises, and organ dysfunction improves over days to weeks. This resolution confirms the placenta as the central pathological driver of pre-eclampsia and explains why timing of delivery is the definitive management decision, requiring careful balancing of maternal stabilisation against fetal maturity and wellbeing.
Clinical Connections
Pre-eclampsia may present with hypertension and proteinuria, but early features can be subtle and extend beyond blood pressure alone. Headache, visual disturbance, epigastric or right upper quadrant pain, oedema, and reduced fetal growth reflect widespread endothelial dysfunction affecting cerebral, hepatic, renal, and placental circulation. Symptoms may escalate abruptly because vascular injury progresses systemically rather than following a slow, organ-by-organ pattern. The absence of severe symptoms at presentation does not indicate stability, as endothelial disruption can advance rapidly once established.
Several clinical features signal multisystem involvement rather than isolated hypertension:
Worsening headache or visual changes indicating cerebral vasospasm and impaired autoregulation
Epigastric or right upper quadrant pain reflecting hepatic microvascular injury and capsular distension
Reduced fetal growth or abnormal Doppler findings due to impaired uteroplacental perfusion
Management is therefore directed at limiting maternal vascular injury while assessing fetal wellbeing. Close monitoring of renal function, liver enzymes, coagulation status, and neurological symptoms is required because deterioration may precede overt clinical collapse.
Blood pressure control reduces the risk of cerebral haemorrhage, while seizure prophylaxis targets endothelial-driven cerebral irritability rather than treating seizures once they occur. Decisions around delivery balance the maternal risks of ongoing endothelial injury against fetal maturity, recognising that removal of the placenta is the only definitive way to halt disease progression. Early recognition and escalation of care are critical to preventing progression to eclampsia, stroke, hepatic rupture, or placental abruption.
Concept Check
Why does abnormal spiral artery remodelling impair placental perfusion?
How does placental ischaemia lead to systemic endothelial dysfunction?
Why is proteinuria a marker of endothelial injury rather than primary kidney disease?
How does endothelial dysfunction cause both oedema and intravascular depletion?
Why is placental delivery the definitive treatment for pre-eclampsia?